About JB
JB is a publicly listed company based in Mumbai (India) founded in 1976, and was acquired by Torrent Pharma in June 2025. Generic drugs are manufactured by JB in Mumbai, India. The company has 7,650 employees. Its chief executive, as recorded, is Nikhil Chopra. Its website jbpharma.com draws about 21 thousand monthly visits. Its Indian entity J B Chemicals And Pharmaceuticals Limited reported revenue of βΉ3,945 Cr. JB offers products and services including Pharmaceutical Formulations and Lozenges. Its focus areas include Traditional Pharmaceuticals.
Company details
JB was established in 1976 in Mumbai, India, within the pharmaceutical sector. Generic drugs are produced by the company, focusing on manufacturing operations. The headquarters are located in Mumbai, where core activities are managed. Nikhil Chopra is designated as CEO. The companys online presence is maintained through the domain jbpharma.com. Geographic focus remains centered in India for production and distribution.
- Headquarters Mumbai, India
- Employees 7,650
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website jbpharma.com
- Social LinkedIn X Facebook
- Acquired by Torrent Pharma (Jun 2025)
- Legal Name Jb Chemicals & Pharmaceuticals Ltd.
- Annual Revenue₹3,945 Cr
FY 2026 · +6% YoY
- Net Profit₹709 Cr
FY 2026 · 17% margin
- EBITDA₹1,140 Cr
FY 2026 · 27% margin
- InvestorsKKR
& 1 more
- Employee Count7,650
- Acquired by
Associated legal entities of JB
JB is associated with 2 registered companies on The Company Check; the primary company is J B Chemicals And Pharmaceuticals Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| J B Chemicals And Pharmaceuticals Limited Listed CIN L24390GJ1976PLC173077 | Amalgamated | 18 Dec 1976 | Ahmedabad, Gujarat | ₹3,945 Cr | 5,984 | 10 | View details |
| J. B. Chemicals & Pharmaceuticals Limited CIN L24390MH1976PLC019380 | 18 Dec 1976 | Mumbai, Maharashtra, India | View details |
Products & Services of JB
JB offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Lozenges.
Formulations are manufactured across various therapeutic categories to meet global demands.
Lozenges are developed and supplied for therapeutic purposes in multiple markets.
Investors in JB
JB has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR and Torrent Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Formulations, APIs, drug discovery, marketing, and sales services are provided. | 1959 | torrentpharma.com | Ahmedabad, India |
Investor details for JB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of J B Chemicals And Pharmaceuticals Limited (JB)
J B Chemicals And Pharmaceuticals Limited is the primary company behind JB. The board of J B Chemicals And Pharmaceuticals Limited currently have 8 directors; the longest-serving is Sumit Bose, appointed in 2020. 48 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sumit Bose DIN 03340616 | Director | 31 Aug 2020 | 6 yrs 2 mo | J B Chemicals And Pharmaceuticals Limited |
| Arun Duggal DIN 00024262 | Director | 05 Jul 2024 | 2 yrs 4 mo | J B Chemicals And Pharmaceuticals Limited |
| Ashwani Kumar Puri DIN 00160662 | Director | 14 May 2025 | 1 yr 6 mo | J B Chemicals And Pharmaceuticals Limited |
| Richa Arora DIN 07144694 | Director | 10 Jul 2025 | 1 yr 4 mo | J B Chemicals And Pharmaceuticals Limited |
| Aman Samir Mehta DIN 08174906 | Managing Director | 21 Jan 2026 | 9 mo | J B Chemicals And Pharmaceuticals Limited |
| Sudhir Menon DIN 09502215 | Director | 21 Jan 2026 | 9 mo | J B Chemicals And Pharmaceuticals Limited |
| Amal Satyawan Kelshikar DIN 06378987 | Director | 21 Jan 2026 | 9 mo | J B Chemicals And Pharmaceuticals Limited |
| Hasmukh Mathurbhai Patel DIN 11486584 | Director | 21 Jan 2026 | 9 mo | J B Chemicals And Pharmaceuticals Limited |
People of JB
48 people are tracked at JB (22 in leadership, 2 in board & advisors, 24 in team); the tracked headcount is 7,650.
| Name | Role | Group |
|---|---|---|
Nikhil Chopra | CEO | Leadership |
Kunal Khanna | President – Operations | Leadership |
Manoj Chitnis | Vice President (corporate Quality Head) | Leadership |
Amit Nayak | Assistant Vice President, Commercial Excellence Head | Leadership |
Issac Lazarus | General Manager Marketing | Leadership |
Ruchi Saboo-Tekle | Deputy General Manager | Leadership |
Sandeep Nasa | Director – Russia, Ukraine & CIS Business (OOOUPL) | Leadership |
Suresh Bhise | Vice President – Information & Technology | Leadership |
Jason D’souza | Executive Vice President | Leadership |
Pradeep Kumar Singh | President – Global Business | Leadership |
Sandeep Phadnis | Vice President – Secretarial | Leadership |
Parmeshwar Bang | Executive Vice President – Operations (Daman) | Leadership |
Sujay Rajhans | President – Research & Development | Leadership |
Sridhar Bharadwaj | Vice President – Human Resources & Administration | Leadership |
Anurag Agrawal | Vice President Regulatory Affairs | Leadership |
Bharatsinh Parmar | General Manager Human Resources | Leadership |
Kadir Idariya | Sr General Manager & Head-marketing | Leadership |
Vikrant Bendre | Head ROW (sales And Marketing) | Leadership |
Ajay Singh | Senior General Manager - Global Business | Leadership |
Dilip Singh Rathore | President – India Business | Leadership |
28 more people are available in the full profile.
Complete people profiles for JB
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of JB
JB is a publicly listed company on the NSE with ticker symbol JBCHEPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Jul 2002
- Listed onNSE: JBCHEPHARM
- Listed entityJB Chemicals & Pharmaceuticals Ltd.
- Exchange sectorHealth technology
- ISININE572A01036
- Share price₹2,209.20 (+2.76% on the day) · 2026-05-11
- Market capitalisation₹34,551 Cr
- Price to earnings46.6
- EPS (diluted, trailing year)₹47.45
- Dividend yield0.92%
- Volume (last session)584,031
- Analyst consensusBuy
Financials of JB
Figures of J B Chemicals And Pharmaceuticals Limited, the primary company behind JB, for FY 2026. Revenue was ₹3,945 Cr (+6% year on year). Net profit was ₹709 Cr (17% margin). EBITDA was ₹1,140 Cr (27% margin). Revenue has grown at a compounded annual rate of +10% over three years and +14% over five years.
- ₹3,945 CrRevenue · FY 2026 · +6% YoY
- ₹709 CrNet profit · 17% margin
- ₹1,140 CrEBITDA · 27% margin
- ₹16.06 CrPaid-up capital
- 5,984Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | ₹3,892 Cr | ₹660 Cr | ₹1,017 Cr |
| 2023 | ₹3,468 Cr | ₹553 Cr | ₹893 Cr |
| 2022 | ₹3,130 Cr | ₹410 Cr | ₹699 Cr |
| 2021 | ₹2,403 Cr | ₹385 Cr | ₹533 Cr |
| 2020 | ₹2,003 Cr | ₹448 Cr | ₹524 Cr |
Balance sheet, profit and loss, cash flow and ratios of J B Chemicals And Pharmaceuticals Limited are on its company page.
Detailed financial statements for JB
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of JB
4 dated milestones of JB across 49 years, from founding to its latest funding, stage changes and deals.
- Founded JB is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by KKR.
- Exit Acquired by Torrent Pharma.
Web traffic of JB
The website of JB (jbpharma.com) receives about 21.3K visits a month.
- Monthly visits21.3K
▼ 35.5% vs previous month
Websites whose visitors overlap most with JB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| torrentpharma.com | 100% | 31.6K | #932,209 | View details | |
| macleodspharma.com | 98% | 23.3K | #522,868 | View details | |
| aurobindo.com | 98% | 24.4K | #1,029,164 | View details | |
| glenmarkpharma.com | 95% | 106.3K | #278,385 | View details | |
| mangalamdrugs.com | 75% | 9.9K | #1,747,627 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 27 similar websites and full traffic analytics for JB
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as JB (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 72.52 M | 1,115 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jb
Complete news archive for JB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JB
JB was founded in 1976.
JB is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Nikhil Chopra is the CEO of JB, as recorded in our data.
JB has 7,650 employees.
The primary company behind JB, J B Chemicals And Pharmaceuticals Limited, reported revenue of βΉ3,945 Cr for FY 2026, up 6% year on year.
JB was established in 1976 in Mumbai, India, within the pharmaceutical sector. Generic drugs are produced by the company, focusing on manufacturing operations. The headquarters are located in Mumbai, where core activities are managed. Nikhil Chopra is designated as CEO. The companys online presence is maintained through the domain jbpharma.com. Geographic focus remains centered in India for production and distribution.
JB offers Pharmaceutical Formulations and Lozenges.
Yes, JB is publicly traded on NSE under the ticker symbol JBCHEPHARM.
JB has 2 investors. Key investors include KKR, and Torrent Pharma.
JB operates through J B Chemicals And Pharmaceuticals Limited.
Yes. JB was acquired by Torrent Pharma in June 2025.
The legal entities of JB currently have 10 directors, including Sandeep Anil Phadnis, Sumit Bose, Aman Samir Mehta and others.

